ProfileGDS4718 / 205475_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 37% 92% 32% 35% 34% 40% 34% 42% 37% 39% 36% 36% 40% 32% 46% 36% 37% 38% 38% 37% 32% 37% 39% 37% 36% 43% 42% 35% 33% 38% 52% 32% 36% 43% 37% 40% 36% 35% 93% 41% 39% 49% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.576631
GSM549102patient 115, normal, homogenized [OPG study]4.8955537
GSM549104patient 119, normal, homogenized [OPG study]9.644292
GSM549108patient 138, normal, homogenized [OPG study]4.6661732
GSM549119patient 077, normal, homogenized [OPG study]4.7606635
GSM549133patient 032, cancer, homogenized [OPG study]4.662734
GSM549139patient 042, cancer, homogenized [OPG study]4.9545740
GSM549099patient 107, normal, homogenized [OPG study]4.7149234
GSM549109patient 139, normal, homogenized [OPG study]5.1280442
GSM549110patient 046, normal, homogenized [OPG study]4.8720237
GSM549114patient 063, normal, homogenized [OPG study]4.875239
GSM549122patient 082, normal, homogenized [OPG study]4.8217536
GSM549134patient 033, cancer, homogenized [OPG study]4.8163736
GSM549136patient 036, cancer, homogenized [OPG study]4.9083440
GSM549140patient 044, cancer, homogenized [OPG study]4.6044232
GSM549111patient 047, normal, homogenized [OPG study]5.2974846
GSM549113patient 057, normal, homogenized [OPG study]4.7335636
GSM549132patient 031, cancer, homogenized [OPG study]4.8107137
GSM549137patient 038, cancer, homogenized [OPG study]4.8558438
GSM549142patient 047, cancer, homogenized [OPG study]4.9989738
GSM549100patient 110, normal, homogenized [OPG study]4.8527837
GSM549107patient 135, normal, homogenized [OPG study]4.5791632
GSM549115patient 068, normal, homogenized [OPG study]4.768837
GSM549116patient 072, normal, homogenized [OPG study]4.9071539
GSM549120patient 078, normal, homogenized [OPG study]4.8306937
GSM549131patient 030, cancer, homogenized [OPG study]4.7366736
GSM549118patient 074, normal, homogenized [OPG study]5.1162443
GSM549129patient 027, cancer, homogenized [OPG study]5.0823142
GSM549123patient 088, normal, homogenized [OPG study]4.7265635
GSM549124patient 006, cancer, homogenized [OPG study]4.7132633
GSM549126patient 015, cancer, homogenized [OPG study]4.8848138
GSM549128patient 025, cancer, homogenized [OPG study]5.6484752
GSM549103patient 117, normal, homogenized [OPG study]4.6894632
GSM549117patient 073, normal, homogenized [OPG study]4.7559736
GSM549138patient 041, cancer, homogenized [OPG study]5.1187843
GSM549141patient 045, cancer, homogenized [OPG study]4.7865337
GSM549130patient 028, cancer, homogenized [OPG study]4.9898940
GSM549101patient 111, normal, homogenized [OPG study]4.8177136
GSM549105patient 128, normal, homogenized [OPG study]4.7772135
GSM549106patient 134, normal, homogenized [OPG study]9.9099793
GSM549112patient 048, normal, homogenized [OPG study]5.0145341
GSM549125patient 011, cancer, homogenized [OPG study]4.9414139
GSM549127patient 024, cancer, homogenized [OPG study]5.4609749
GSM549135patient 035, cancer, homogenized [OPG study]4.6437834